Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127109931 | 12710993 | 1 | I | 201605 | 20160517 | 20160902 | 20160902 | EXP | US-LANNETT COMPANY, INC.-US-2016LAN001579 | LANNETT | 0.00 | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127109931 | 12710993 | 1 | PS | RABEPRAZOLE SODIUM. | RABEPRAZOLE SODIUM | 1 | 20 MG, QD, 20 MG, ONCE DAILY (QD) | U | 90678 | 20 | MG | ||||||||
| 127109931 | 12710993 | 2 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127109931 | 12710993 | 1 | Gastrooesophageal reflux disease |
| 127109931 | 12710993 | 2 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127109931 | 12710993 | Drug ineffective | |
| 127109931 | 12710993 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127109931 | 12710993 | 1 | 201605 | 0 |